1. 02.18 Can rankl serum levels predict future progression to rheumatoid arthritis in early arthritis clinic patients?. (1st March 2017) Authors: Burska, Agata N; El-Jawhari, Jehan J; Tan, Ai L; Wakefield, Richard J; Marzo-Ortega, Helena; Conaghan, Philip G; Emery, Paul; Ponchel, Frederique; Freeston, Jane E Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 1 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1.63 IL-7 drives the tissue architecture of the RA synovium providing a niche for B-cells to mature. (31st January 2014) Authors: Churchman, Sarah M; El-Jawhari, Jehan; Goeb, Vincent; Vital, Ed; El-Sherbini, Yasser; Conaghan, Philip G; Emery, Paul; Ponchel, Frederique Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 1(2014) Page Start: A27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 152 The OMERACT-OARSI core domain set for measurement in clinical trials of hip and/or knee osteoarthritis. (12th April 2019) Authors: Smith, Toby; Conaghan, Philip G Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 169 Secukinumab provides sustained reduction in fatigue in patients with active psoriatic arthritis through three years: long-term data from the FUTURE 1 and FUTURE 2 studies. (25th April 2018) Authors: Chinoy, Hector; Gossec, Laure; Kvien, Tore K; Conaghan, Philip G; Østergaard, Mikkel; Gladman, Dafna; Mease, Philip; Rasouliyan, Lawrence; Pricop, Luminita; Gaillez, Corine; Jugl, Steffen Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 176 Secukinumab provides sustained reduction in fatigue in patients with ankylosing spondylitis through three years: long-term results of two randomised double-blind placebo-controlled phase III studies. (25th April 2018) Authors: Marzo-Ortega, Helena; Kvien, Tore K; Deodhar, Atul A; Gossec, Laure; Conaghan, Philip G; Strand, Vibeke; Østergaard, Mikkel; Williams, Nicole; Porter, Brian; Gandi, Kunal; Jugl, Steffen Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A modification of the Omeract RA MRI score for erosions for use with an extremity MRI system with reduced field of view. Issue 12 (6th July 2007) Authors: Freeston, Jane E; Olech, Ewa; Yocum, David; Hensor, Elizabeth M A; Emery, Paul; Conaghan, Philip G Journal: Annals of the rheumatic diseases Issue: Volume 66:Issue 12(2007) Page Start: 1669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A novel method for bone area measurement provides new insights into osteoarthritis and its progression. Issue 3 (4th December 2013) Authors: Bowes, Michael A; Vincent, Graham R; Wolstenholme, Christopher B; Conaghan, Philip G Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 3(2015) Page Start: 519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study. Issue 8 (13th May 2020) Authors: Emery, Paul; Burmester, Gerd R; Naredo, Esperanza; Sinigaglia, Luigi; Lagunes, Ivan; Koenigsbauer, Franziska; Conaghan, Philip G Journal: Annals of the rheumatic diseases Issue: Volume 79:Issue 8(2020) Page Start: 1023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY). Issue 1 (5th May 2012) Authors: Dougados, Maxime; Kissel, Karsten; Sheeran, Tom; Tak, Paul P; Conaghan, Philip G; Mola, Emilio Martín; Schett, Georg; Amital, Howard; Navarro-Sarabia, Federico; Hou, Antony; Bernasconi, Corrado; Huizinga, TWJ Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 1(2013) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. An immunological biomarker to predict MTX response in early RA. Issue 11 (29th August 2013) Authors: Ponchel, Frederique; Goëb, Vincent; Parmar, Rekha; El-Sherbiny, Yasser; Boissinot, Marjorie; El Jawhari, Jehan; Burska, Agata; Vital, Edward M; Harrison, Stephanie; Conaghan, Philip G; Hensor, Elizabeth; Emery, Paul Journal: Annals of the rheumatic diseases Issue: Volume 73:Issue 11(2014) Page Start: 2047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗